Skip to main content
Subscribe
Register
Sign in
Membership
Insights
Events
About
Subscribe
Register
Sign in
Michelle Celarier
Latest Articles
Premium
Larry Robbins’ Healthcare Bets Drag Down Glenview
Michelle Celarier
March 4, 2020
Premium
Pot Stock Short Sellers Seeing Green Again
Michelle Celarier
February 26, 2020
Premium
Hedge Funds Dumped Peloton Ahead of Looming Lockup Expiration
Michelle Celarier
February 21, 2020
Premium
The Obscure Hedge Fund Betting Huge on Herbalife
Michelle Celarier
February 21, 2020
Premium
Bruce Berkowitz Is Back!
Michelle Celarier
February 18, 2020
‘If a Charge Can’t Stick on These Guys, No Charges Can Stick on Anyone.’
Michelle Celarier
February 18, 2020
Premium
A Tesla Short Seller Bares His Soul
Michelle Celarier
February 11, 2020
Premium
Ackman Starts 2020 Slightly Down, but Celebrates a Big 2019
Michelle Celarier
February 6, 2020
McKinsey’s Managed Accounts Come Under Scrutiny in Trial
Michelle Celarier
February 5, 2020
Premium
More Trouble for David Einhorn?
Michelle Celarier
January 29, 2020
Premium
Unicorn Comeback Helps Tiger Global, Viking, Valiant, and Others
Michelle Celarier
January 28, 2020
Premium
Tesla Boosted Worm Capital in 2019
Michelle Celarier
January 24, 2020
Premium
Fahmi Quadir’s Safkhet Capital is Still Short Wirecard
Michelle Celarier
January 23, 2020
Premium
Muirfield’s GSE Fund Soared in 2019
Michelle Celarier
January 16, 2020
Premium
Did the Platinum Partners Trial Judge Usurp the Jury’s Role in Overturning Verdicts?
Michelle Celarier
January 15, 2020
Premium
Tesla’s Comeback Puts Stanphyl Capital in the Red Yet Again
Michelle Celarier
January 8, 2020
Premium
Hedge Funds’ Stock Winners — and Losers — of the Decade
Michelle Celarier
January 7, 2020
Premium
Bill Ackman Finishes 2019 With a Bang
Michelle Celarier
January 3, 2020
More Articles